GLENMARK PHARMACEUTICALS LTD.
Market Cap.(`)
|
49492.38 Cr.
|
P/BV
|
5.86
|
Book Value (`)
|
299.28
|
52 Week High/Low ( ` )
|
1831/1232
|
FV/ML
|
1/1
|
P/E(X)
|
47.27
|
Book Closure
|
27/09/2024
|
EPS (`)
|
37.10
|
Div Yield (%)
|
0.14
|
You can view Board Meetings,AGM/EGM of the company.
Board Meetings
Date of Meeting | Purpose |
23/05/2025 | Audited Results & Final Dividend |
14/02/2025 | Quarterly Results |
14/11/2024 | Quarterly Results |
14/08/2024 | Quarterly Results |
24/05/2024 | Audited Results & Final Dividend |
14/02/2024 | Quarterly Results |
10/11/2023 | Quarterly Results |
11/08/2023 | Quarterly Results |
AGM/EGM
Annt. Date | Purpose | Book Closure Start | Book Closure End | Remarks |
26/03/2025 | POM | - | - |
|
30/08/2024 | AGM | 17/09/2024 | 27/09/2024 |
|
06/10/2023 | POM | - | - |
|
25/08/2023 | AGM | 19/09/2023 | 29/09/2023 |
|
05/07/2023 | POM | - | - |
|
15/03/2023 | POM | - | - |
|